Top Retellings of Classic Tales

Andre Grillon
Andre’s Kindle Notes & Highlights
A Crack In Creation: A Nobel Prize Winner's Insight into the Future of Genetic Engineering, by Jennifer A. Doudna

52%
Flag icon
Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies, and Intellia Therapeutics has partnered with the major health-care firm Novartis to similarly pursue cancer immunotherapy.
See Andre’s 305 highlights
A Crack In Creation: A Nobel Prize Winner's Insight into the Future of Genetic Engineering
A Crack In Creation: A Nobel Prize Winner's Insight into the Future of Genetic Engineering
by Jennifer A. Doudna
Rate this book
Clear rating
1 of 5 stars2 of 5 stars3 of 5 stars4 of 5 stars5 of 5 stars
Open Preview